Graybill Bartz & Assoc LTD Bristol Myers Squibb CO Transaction History
Graybill Bartz & Assoc LTD
- $271 Million
- Q1 2025
A detailed history of Graybill Bartz & Assoc LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Graybill Bartz & Assoc LTD holds 8,567 shares of BMY stock, worth $428,864. This represents 0.19% of its overall portfolio holdings.
Number of Shares
8,567Holding current value
$428,864% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,783Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.51 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.94 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.81 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.76 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.02 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...